🇺🇸 FDA
Patent

US 7829712

Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

granted A61KA61K31/501A61P

Quick answer

US patent 7829712 (Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase) held by Xenon Pharmaceuticals Inc. expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/501, A61P, A61P1/16, A61P3/00